Diabetes mellitus is a chronic metabolic disorder and one of the most prevalent non-communicable diseases worldwide. On average, one in ten adults is affected. The number of people living with diabetes continues to rise, posing […]
An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important role in shaping the developing immune system during early childhood.This article was originally published on MedicalXpress.com
Higher consumption of food preservatives, widely used in industrially processed foods and beverages to extend their shelf life, has been linked to an increased risk of type 2 diabetes.This article was originally published on MedicalXpress.com
A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared to those taking glucagon-like […]
Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical utility study demonstrating that the PromarkerD blood test provides actionable information that significantly changes how doctors manage patients with type […]
People with type 2 diabetes may be able to improve their blood sugar by doing something as simple as sitting by a window for a few hours each day. In a study published in Cell […]
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may protect against vertebral fractures in people with diabetes, according to a research letter published online Dec. 10 in JAMA Surgery.This article was originally published on MedicalXpress.com
Texture analysis can identify retinal changes during early stages of type 2 diabetes, according to a study published in Eye Vision.This article was originally published on MedicalXpress.com
A healthy Nordic diet, high in dietary fiber from whole grains, fruits and vegetables but with a small percentage of saturated fat, can assist in the treatment of both type 2 diabetes and non-alcoholic fatty […]
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published in Neurology.This article was originally published on […]
© 2025 SimplyWell.ca